Prognostic Significance of Preoperative Hemoglobin A1c (HbA1c) in Renal Cell Carcinoma

Clinical trial NCT02417194 · UNKNOWN

Trial details

NCT number: NCT02417194
Sponsor: Seoul National University Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Carcinoma, Renal Cell Pathology Treatment Outcome Hemoglobin A1c Protein, Human

Start date: 2015-04-01
Primary completion: 2018-04-01
Enrollment: 238

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.